Insider Transactions in Q4 2024 at Novavax Inc (NVAX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
James Patrick Kelly EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,906
-34.15%
|
$135,248
$8.04 P/Share
|
|
Dec 31
2024
|
James Patrick Kelly EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+41.42%
|
-
|
|
Dec 31
2024
|
James F Young |
SELL
Open market or private sale
|
Direct |
5,400
-9.45%
|
$43,200
$8.0 P/Share
|
|
Dec 24
2024
|
James F Young |
SELL
Open market or private sale
|
Direct |
4,600
-7.45%
|
$36,800
$8.48 P/Share
|
|
Dec 13
2024
|
Rachel K. King |
SELL
Open market or private sale
|
Direct |
4,150
-21.93%
|
$37,350
$9.02 P/Share
|
|
Dec 11
2024
|
Mark J Casey EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,713
-30.34%
|
$101,704
$8.82 P/Share
|
|
Dec 11
2024
|
Mark J Casey EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,900
+50.0%
|
-
|
|
Oct 29
2024
|
Richard J Rodgers |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+21.03%
|
-
|